Bifidobacterium longum combined with Lactobacillus reuteri used to reduce anxiety and depression in postoperative chemotherapeutic patients with colorectal cancer: a Prospective, Single center, Randomized controlled clinical study

ABSTRACT: Interventions: Chemotherapy and placebo group:Placebo;Chemotherapy and probiotic group:Oral probiotics;Non-chemotherapy and placebo group:Placebo;Non-chemotherapy and probiotic group:Oral probiotics Primary outcome(s): Anxiety and Depression Symptoms (HAD) Study Design: Randomized parallel controlled trial

DISEASE(S): Colorectal Cancer

PROVIDER: 2677689 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR